The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 14,801–14,900 of 31,469
Metabolic Syndrome in the Pediatric Population: A Short Overview
Varda, N. M., & Gregorič, A. (2009) · Pediatric Reports · doi:10.4081/pr.2009.e1 · Cited by 21
Faggiano, A., Pivonello, R., Melis, D., Alfieri, R., Filippella, M., Spagnuolo, G., Salvatore, F., Lombardi, G., & Colao, A. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03343978 · Cited by 23
Anan, F., Masaki, T., Iwao, T., Eto, T., Shimomura, T., Umeno, Y., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802061818 · Cited by 21
de Luis, D. A., Sagrado, M. G., Aller, R., Izaola, O., Conde, R., & Romero, E. (2010) · PubMed · Cited by 21
Zheng, Y., Wang, L., Fan, X., Wu, C., Huo, N., Lu, H. ‐., Xu, X., & Wei, L. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2012.01644.x · Cited by 21
Effect of exercise on postprandial endothelial function in adolescent boys
Sedgwick, M. J., Morris, J. G., Nevill, M. E., Tolfrey, K., Nevill, A. M., & Barrett, L. A. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512004977 · Cited by 21
Al‐Hakeim, H. K., & Abdulzahra, M. S. (2014) · Journal of Medical Biochemistry · doi:10.2478/jomb-2014-0033 · Cited by 21
López, L. V., González–Figueroa, E., Medina‐Bravo, P., Aguila, I. P.-D., Ávila-Jiménez, L., Ramos-Hernández, R. I., Klünder‐Klünder, M., & Escobedo, J. (2012) · Endocrine · doi:10.1007/s12020-012-9775-z · Cited by 27
Obese adolescents with eating disorders: Analysis of metabolic and inflammatory states
Carnier, J., Sanches, P. D. L., da Silva, P. L., de Piano, A., Tock, L., Campos, R. M. D. S., Corgosinho, F. C., Corrêa, F. A., Masquio, D. C. L., do Nascimento, C. M. O., et al. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.08.014 · Cited by 21
Ingelsson, E., Ärnlöv, J., Sundström, J., Risérus, U., Michaëlsson, K., & Byberg, L. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328319bf8c · Cited by 21
Benaicheta, N., Labbaci, F. Z., Bouchenak, M., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515004195 · Cited by 21
Gysel, T., Calders, P., Cambier, D. C., de Mettelinge, T. R., Jm, K., Taes, Y., Zmierczak, H., & Goemaere, S. (2014) · PubMed · Cited by 21
Rašić-Milutinović, Z., Peruničić-Peković, G., Cavala, A., Gluvic, Z. M., Bokan, L., & Stankovic, S. D. (2008) · PubMed Central · Cited by 21
Weight‐HbA1c‐insulin‐glucose model for describing disease progression of type 2 diabetes
Choy, S., Kjellsson, M., Karlsson, M., & de Winter, W. (2015) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12051 · Cited by 21
Antidiabetic activity of Helicteres angustifolia root
Hu, X., Cheng, D., & Zhang, Z. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1077871 · Cited by 21
Coşkun, T., Kosova, F., Arı, Z., et al. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.815 · Cited by 21
Age-related differences in plasma BDNF levels after prolonged bed rest
Soavi, C., Marušič, U., Sanz, J. M., Morieri, M. L., Nora, E. D., Šimunič, B., Pišot, R., Zuliani, G., & Passaro, A. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01111.2015 · Cited by 21
Adami, G. F., Gradaschi, R., Andraghetti, G., Scopinaro, N., & Cordera, R. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2126-z · Cited by 21
Faure, C., Charlot, K., Henri, S., Hardy‐Dessources, M., Hüe, O., & Antoine‐Jonville, S. (2016) · Clinical Science · doi:10.1042/cs20150461 · Cited by 21
Binnetoğlu, F. K., Yıldırım, Ş., Topaloğlu, N., Tekin, M., Kaymaz, N., Aylanç, H., & Karakurt, H. (2014) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2014.5189 · Cited by 21
Insulin Resistance and Impaired Mitochondrial Function in Obese Adolescent Girls
Slattery, M. J., Bredella, M. A., Thakur, H., Torriani, M., & Misra, M. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0100 · Cited by 21
Trovato, G. M., Martines, G. F., Pirri, C., Trovato, F. M., Castro, A., Garozzo, A., & Catalano, D. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31824b225c · Cited by 21
Maldonado‐Martín, S., Gorostegi-Anduaga, I., Aispuru, G. R., Illera-Villas, M., Jurio-Iriarte, B., Francisco-Terreros, S., & Pérez-Asenjo, J. (2016) · Journal of Clinical Trials · doi:10.4172/2167-0870.1000252 · Cited by 21
Yıldızhan, B., İlhan, G. A., & Pekin, T. (2016) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2016.1168376 · Cited by 21
Lee, M., Ebert, J. R., Kadakia, M., Zhang, J., & Czerwinski, S. A. (2016) · American Journal of Human Biology · doi:10.1002/ajhb.22863 · Cited by 21
Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21
Han, S., Kim, J. D., Lee, S., Jeong, A. L., Park, J. S., Yong, H. J., Boldbaatar, A., Ka, H. I., Rhee, E., Lee, W., et al. (2016) · International Journal of Endocrinology · doi:10.1155/2016/5479627 · Cited by 21
Stawerska, R., Zawodniak-Szałapska, M., Hilczer, M., et al. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0463 · Cited by 21
Hamza, R. T., Ahmed, A. Y., Rezk, D. G., & Hamed, A. I. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0015 · Cited by 21
Chan, D. C., Pang, J., Barrett, P. H. R., SULLIVAN, D. R., Mori, T. A., Burnett, J. R., van BOCKXMEER, F. M., & Watts, G. F. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.07.012 · Cited by 21
Vileigas, D. F., de Deus, A. F., da Silva, D. C. T., de Tomasi, L. C., de Campos, D. H. S., Adorni, C. S., de Oliveira, S. M., Sant’Ana, P. G., Okoshi, K., Padovani, C. R., et al. (2016) · Physiological Reports · doi:10.14814/phy2.12914 · Cited by 21
Kornum, D. S., Støy, J., Kampmann, U., Voss, T. S., Madsen, L. R., Møller, N., & Ovesen, P. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000237 · Cited by 22
Huang, X.-Y., Zhang, L., Sun, J., Xu, N., & Wei, Y. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/9651592 · Cited by 21
Lee, J.-E., Min, S. H., Lee, D., Oh, T. J., Kim, K. M., Moon, J. H., Choi, S. H., Park, K. S., Jang, H. C., & Lim, S. K. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.015 · Cited by 21
Castro, H., Pomar, C. A., Palou, A., Picó, C., & Sánchez, J. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600513 · Cited by 21
Méndez‐Hernández, P., Dosamantes-Carrasco, L. D., Siani, C., Pierlot, R., Martı́nez–Gómez, M., Rivera‐Paredez, B., Cervantes-Popoca, L., Rojas-Lima, E., Salazar-Martínez, E., Flóres, Y. N., et al. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516003329 · Cited by 21
Li, T., Chen, K., Liu, G., Huang, L., Chen, L., Wang, Q., Hu, C., & Hou, L. (2016) · Pediatric Research · doi:10.1038/pr.2016.273 · Cited by 24
Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypass
Bojsen-Møller, K. N., Dirksen, C., Svane, M. S., Jørgensen, N. B., Holst, J. J., Richter, E. A., & Madsbad, S. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00291.2016 · Cited by 22
Ma, H., Lin, H., Hu, Y., Li, X., He, W., Jin, X., Gao, J., Zhao, N., Pan, B., & Gao, X. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0451-4 · Cited by 21
Pennathur, S., Jaiswal, M., Vivekanandan-Giri, A., White, E. A., Ang, L., Raffel, D. M., Rubenfire, M., & Pop-Busui, R. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.03.008 · Cited by 21
Itcho, K., Yoshii, Y., Ohno, H., Oki, K., Shinohara, M., Irino, Y., Toh, R., Ishida, T., Hirata, K., & Yoneda, M. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.39164 · Cited by 21
Hübers, M., Pourhassan, M., Braun, W., Geisler, C., & Müller, M. J. (2017) · Obesity Science & Practice · doi:10.1002/osp4.121 · Cited by 25
Wang, Y., Chi, J., Che, K., Chen, Y., Sun, X., Wang, Y., & Wang, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180111 · Cited by 21
Klisic, A. N. (2017) · Acta Clinica Croatica · doi:10.20471/acc.2017.56.01.14 · Cited by 21
Koloverou, E., Panagiotakos, D. B., Georgousopoulou, E. N., Chrysohoou, C. A., Tousoulis, D. M., Stefanadis, C., Pitsavos, C. S., & ATTICA Study Group (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2939 · Cited by 21
Pesola, A. J., Laukkanen, A., Heikkinen, R., Sipilä, S., Sääkslahti, A., & Finni, T. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183299 · Cited by 24
Verroken, C., Zmierczak, H., Goemaere, S., Kaufman, J., & Lapauw, B. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3303 · Cited by 21
Kern, D. M., Auchincloss, A. H., Stehr, M. F., Roux, A. V. D., Moore, K., Kanter, G. P., & Robinson, L. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.10.029 · Cited by 22
Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington’s disease
Sjögren, M., Duarte, A. I., McCourt, A. C., Shcherbina, L., Wierup, N., & Björkqvist, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-13713-5 · Cited by 21
Önnerfält, J., Erlanson‐Albertsson, C., Montelius, C., & Thorngren‐Jerneck, K. (2017) · Acta Paediatrica · doi:10.1111/apa.14165 · Cited by 21
Agostinis-Sobrinho, C., Ramírez-Vélez, R., García-Hermoso, A., Moreira, C., Lopes, L., Oliveira-Santos, J., Abreu, S., Mota, J., & Santos, R. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12607 · Cited by 25
Kim, T. N., Park, M. S., Lee, E. J., Chung, H. S., Yoo, H. J., Kang, H. J., Song, W., Baik, S. H., & Choi, K. M. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2974 · Cited by 21
Wei, M., Shao, Y., Liu, Q.-R., Wu, Q., Zhang, X., Zhong, M., Liu, S.-Z., Zhang, G., & Hu, S. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00311.2017 · Cited by 21
Insulin resistance and the increased risk for smell dysfunction in US adults
Min, J., & Min, K. (2018) · The Laryngoscope · doi:10.1002/lary.27093 · Cited by 21
Zhou, Y., Hu, C., Zhao, X., Luo, P., Lu, J., Li, Q., Chen, M., Yan, D., Lu, X., Kong, H., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00866 · Cited by 21
Retnakaran, R. R., Choi, H., Ye, C., Kramer, C. K., & Zinman, B. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13236 · Cited by 21
GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr−/− mice
Silva, J. C., de Oliveira, E. M., Turato, W. M., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0011-7 · Cited by 21
Loves, S., van Groningen, L. F. J., Filius, M., Mekking, M., Brandon, T., Tack, C. J., Hermus, A. R., & de Boer, H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00161 · Cited by 22
Hu, Y., Liu, J., Wang, G., & Xu, Y. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0435-z · Cited by 21
Romo‐Hualde, A., Huerta, A. E., González-Navarro, C. J., Ramos-López, O., Moreno-Aliaga, M. J., & Martínez, J. A. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0750-4 · Cited by 25
Pavanello, S., Angelici, L., Hoxha, M., Cantone, L., Campisi, M., Tirelli, A. S., Vigna, L., Pesatori, A. C., & Bollati, V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00309 · Cited by 20
Maslova, E., Rifas-Shiman, S., Olsen, S., Gillman, M., & Oken, E. (2018) · Nutrition & Diabetes · doi:10.1038/s41387-018-0040-2 · Cited by 19
Angelini, G., Salinari, S., BERTUZZI, A., Iaconelli, A., & Mingrone, G. (2018) · Communications Biology · doi:10.1038/s42003-018-0069-8 · Cited by 21
François, M. E., Gilbertson, N. M., Eichner, N. Z. M., Heiston, E. M., Fabris, C., Breton, M. D., Mehaffey, J. H., Hassinger, T. E., Hallowell, P. T., & Malin, S. K. (2018) · Nutrients · doi:10.3390/nu10060717 · Cited by 22
Sun, Q., Xu, H., Xue, J., Yang, Q., Chen, C., Yang, P., Han, A., Tu, Q., Lü, J., Gao, X., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26800 · Cited by 21
Grarup, N., Moltke, I., Andersen, M. K., Bjerregaard, P., Larsen, C. V. L., Dahl‐Petersen, I. K., Jørsboe, E., Tiwari, H. K., Hopkins, S. E., Wiener, H. W., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4659-2 · Cited by 20
Metabolically healthy and unhealthy obesity phenotypes and risk of renal stone: a cohort study
Kim, S., Chang, Y., Yun, K. E., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0140-z · Cited by 21
Andersson, D. P., Dahlman, I. A., Hogling, D. E., Bäckdahl, J., Toft, E., Qvisth, V., Näslund, E. B., Thorell, A., Rydén, M., & Arner, P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12824 · Cited by 21
Palhares, H. M. D. C., Zaidan, P. C., Dib, F. C. M., et al. (2018) · Revista Paulista de Pediatria · doi:10.1590/1984-0462/;2018;36;3;00017 · Cited by 21
Djohan, Y. F., Badia, É., Bonafos, B., Fouret, G., Lauret, C., Dupuy, A., Pinot, E., Sutra, T., Gaillet, S., Lambert, K., et al. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1854-3 · Cited by 21
Ragy, M. M., & Ahmed, S. M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27808 · Cited by 21
Ahn, N., Kim, H. S., & Kim, K. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02254-7 · Cited by 24
Bourne, J. E., Little, J. P., Beauchamp, M. R., Barry, J., Singer, J., & Jung, M. E. (2019) · JMIR Research Protocols · doi:10.2196/11226 · Cited by 23
Williams, J. S., Stimpson, T. V., Tremblay, J. C., Fenuta, A. M., & Pyke, K. E. (2019) · Experimental Physiology · doi:10.1113/ep087536 · Cited by 22
da Silva, C. D. C., Zambon, M. P., Vasques, A. C. J., Camilo, D. F., Rodrigues, A. M. D. B., Antônio, M. Â. R. D. G. M., Dâmaso, A. R., Tufik, S., de Mello, M. T., Campos, R. M. D. S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214081 · Cited by 21
Alferink, L. J. M., Jong, J. C. K., Erler, N. S., de Knegt, R. J., Hoorn, E. J., Ikram, M. A., Janssen, H. L. A., Metselaar, H. J., Franco, O. H., & Murad, S. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02792 · Cited by 20
The Triaxial Physical Activity Signature Associated with Metabolic Health in Children
Aadland, E., Kvalheim, O. M., Anderssen, S. A., Resaland, G. K., & Andersen, L. B. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002021 · Cited by 21
Hemmati, M., Motamedrad, M., Shokouhifar, A., et al. (2019) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.258494 · Cited by 21
Nam, K. H., An, S. Y., Joo, Y. S., Lee, S., Yun, H., Jhee, J. H., Han, S. H., Yoo, T., Kang, S., & Park, J. T. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060793 · Cited by 21
Hwang, Y., Ahn, H. Y., & Park, C. (2019) · Obesity · doi:10.1002/oby.22536 · Cited by 21
Dludla, P. V., Gabuza, K., Muller, C. J. F., et al. (2018) · Physiological Research · doi:10.33549/physiolres.933891 · Cited by 21
Shitole, S. G., Biggs, M. L., Reiner, A. P., Mukamal, K. J., Djoussé, L., Ix, J. H., Barzilay, J. I., Tracy, R. P., Siscovick, D. S., & Kizer, J. R. (2019) · Diabetes Care · doi:10.2337/dc19-0723 · Cited by 22
Castro, M. C., Villagarcía, H. G., Nazar, A. P., Arbeláez, L. F. G., Massa, M. L., Zotto, H. H. D., Rı́os, J. L., Schinella, G. R., & Francini, F. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112263 · Cited by 21
Dirks, M. L., Wall, B. T., Otten, B., Cruz, A. M., Dunlop, M. V., BARKER, A. R., & Stephens, F. B. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz049 · Cited by 19
Schmidt, K. M. T., Hansen, K. M., Johnson, A. L., Gepner, A. D., Korcarz, C. E., Fiore, M. C., Baker, T. B., Piper, M. E., & Stein, J. H. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013939 · Cited by 21
Konstari, S., Sääksjärvi, K., Heliövaara, M., et al. (2019) · Cartilage · doi:10.1177/1947603519894731 · Cited by 21
Käräjämäki, A. J., Hukkanen, J., Kauma, H., Kesäniemi, Y. A., & Ukkola, O. H. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2019.1700428 · Cited by 22
Kurajoh, M., Fukumoto, S., Murase, T., Nakamura, T., Ishihara, T., Go, H., Yamamoto, K., Nakatani, S., Tsuda, A., Morioka, T., et al. (2019) · International Journal of Endocrinology · doi:10.1155/2019/1762161 · Cited by 22
Elgawish, R. A., El-Beltagy, M. A., El‐Sayed, R. M., Gaber, A. A., & Abdelrazek, H. M. A. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-07509-5 · Cited by 21
Muraca, E., Ciardullo, S., Oltolini, A., Zerbini, F., Bianconi, E., Perra, S., Villa, M., Cannistraci, R., Castoldi, G., Pizzi, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa097 · Cited by 21
Huang, N. K., Matthan, N. R., Galluccio, J. M., Shi, P., Lichtenstein, A. H., & Mozaffarian, D. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa060 · Cited by 21
Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease
Guarnotta, V., Prinzi, A., Pitrone, M., Pizzolanti, G., & Giordano, C. S. D. S. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s249090 · Cited by 22
Joo, H. J., Kim, G. R., Park, E., & Jang, S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17093322 · Cited by 23
RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice
Duggan, B. M., Cavallari, J. F., Foley, K. P., Barra, N. G., & Schertzer, J. D. (2020) · Endocrinology · doi:10.1210/endocr/bqaa086 · Cited by 23
Lee, S. H., Ahn, M. B., Choi, Y. J., Kim, S. K., Kim, S. H., Cho, W. K., Cho, K. S., Suh, B., & Jung, M. H. (2020) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040002.001 · Cited by 21
Hayes, L. D., Herbert, P., Sculthorpe, N. F., & Grace, F. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111074 · Cited by 22
Molecular and functional profiling of human islets: from heterogeneity to human phenotypes
Drigo, R. A. E., Roy, B., & MacDonald, P. E. (2020) · Diabetologia · doi:10.1007/s00125-020-05159-8 · Cited by 22
Ibrahim, F., Samarawickrama, A., Hamzah, L., Vincent, R., Gilleece, Y. C., Waters, L. J., Kegg, S., Barbini, B., Campbell, L. J., Post, F. A., et al. (2020) · HIV Medicine · doi:10.1111/hiv.12961 · Cited by 21
Zupo, R., Castellana, F., Sardone, R., Lampignano, L., Paradiso, S., Giagulli, V. A., Triggiani, V., Lorenzo, L. D., Giannelli, G., & Pergola, G. D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.565065 · Cited by 20
Wang, M., Xiong, Y., Zhu, W., Ruze, R., Xu, Q., Yan, Z., Zhu, J., Zhong, M., Cheng, Y., Hu, S., et al. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05073-3 · Cited by 25
Eid, B. G., Neamatallah, T., Hanafy, A., et al. (2020) · Medicina · doi:10.3390/medicina56110573 · Cited by 21
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
